Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Addpharma Inc.
To evaluate the pharmacokinetic Interaction, safety and tolerability of the combination compared with the single administration of AD-2011 and AD-2012.
Age
19–50
Sex
MALE
Healthy volunteers
Accepted
You may be eligible if
Healthy male between 19 and 50 years of age at the time of screening
Weight between 50 kg and 90 kg and body mass index (BMI) between 18.0 kg/m2 and 27.0 kg/m2
You may not be if
Clinically significant disease or history of clinically significant disease such as liver, kidney, nervous system, respiratory, endocrine\*hematologic, cardiovascular, urinary, psychiatric
Gastrointestinal problem or history of gastrointestinal problem and history of gastrointestinal surgery
AST, ALT values over than 1.5 times of ULN at screening
HDL values less than 35 mg/dL
A person who has a history of drug abuse or who has positive result for an abuse drug in a urine screening test
Clareo Health | Evaluating the Pharmacokinetic Interaction Between AD-2011 and AD-2012
